IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
BELGIUM
BEXAL
Full Name: B.V.B.A. Bexal S.P.R.L.
Street Ad dress: Medialaan 40, bus 1, B-1800
Vilvoorde
Tel: +32 2 722 97 97
Fax: +32 2 722 97 80
CIBA VI SION
Full Name: N.V. CIBA Vi sion Ben elux S.A.
Street Ad dress: Omega Busi ness Park,
Industrieterrein Mechelen Nord II,
Wayenborgstraat 22, B-2800 Mechelen
Tel: +32 1 528 64 00
Fax: +32 1 528 64 03
Home Page: www.cibavision.be
Sub sid iary of: Novartis, Swit zer land (100%)
NOVARTIS
Full Name: Novartis Pharma S.A./N.V.
Street Ad dress: Medialaan 40, Bus 1, B-1800
Vilvoorde
Tel: +32 2 246 16 11
Fax: +32 2 242 37 59
Email: brussels.re cep tion@novartis.com
Home Page: www.novartis.be
De scrip tion: Dis trib u tor, im porter, pro moter,
sales/detailer. Prod uct ranges in clude: phar ma -
ceu ti cal prod ucts (branded, pre scrip tion,
non-pre scrip tion), hos pi tal pharmaceuticals, oph -
thal mic prod ucts. Es tab lished 1997. 350 phar ma -
ceu ti cal employees in 2007.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 101-500 (2007)
Con tacts (Pharm): Chair man: Tom Rossi; Mar -
ket Re search: Michel Gravisse; Gen eral Con tact:
Xa vier Thiriar
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 260-270 mil lion
Prod ucts (% of Sales by Lead ing 5): 45-50%
Ther a peu tic Classes (% of Sales by Lead ing
5): 50-55%
Dose Forms (% of Sales by Lead ing 5):
90-95%
Prin ci pal Prod ucts:
GLIVEC (antineoplastic other)
SANDOSTATINE (hor mone hy po tha lamic)
ZOMETA (bone cal cium reg u la tor)
NEORAL-SANDIMMUN (immunosuppressive
agent)
LUCENTIS (oc u lar antineovascularization prod -
uct)
Ther a peu tic Range:
antineoplastics 15%
renin-an gio ten sin sys tem agents 12%
hor mones pi tu itary and hy po tha lamic 11%
musculoskeletal drugs other 9%
immunosuppressive agents 8%
Lead ing Dose Forms:
coated tab lets 36%
vi als 18%
cap sules 17%
tab lets 12%
in fu sions 9%
NOVARTIS CON SUMER HEALTH
Street Ad dress: Medialaan 30 bus 5, B-1800
Vilvoorde
Tel: +32 2 264 97 00
Fax: +32 2 264 97 05
De scrip tion: Dis trib u tor, pro moter,
sales/detailer. Prod uct ranges in clude: phar ma -
ceu ti cal prod ucts (branded, non-pre scrip tion),
hos pi tal pharmaceuticals. Es tab lished 1923. 61
phar ma ceu ti cal em ploy ees in 2008. Di vi sions
include: Self-Medication.
Rep re sen ta tives/De tail ers (Pharm, Num -
ber): 20 (2008)
Con tacts (Pharm): Chair man: Guy Rombouts;
Com mer cial Op er a tions: Guido Van Hoeck; Mar -
ket Re search: Bart Wellens; Re search & De vel op -
ment: Pieter De Pourcq
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 40-45 mil lion
Prod ucts (% of Sales by Lead ing 5): 75-80%
Ther a peu tic Classes (% of Sales by Lead ing
5): 85-90%
Dose Forms (% of Sales by Lead ing 5):
85-90%
Prin ci pal Prod ucts:
VOLTAREN EMULGEL (antirheumatic top i cal)
OTRIVINE (na sal prep a ra tion top i cal; na sal prep -
a ra tion sys temic)
OROFAR (throat prep a ra tion)
VENORUTON (var i cose ther apy sys temic; var i -
cose ther apy top i cal)
VOLTAPATCH TISSUGE (antirheumatic top i cal)
Ther a peu tic Range:
anti rheu ma tics top i cal 33%
na sal prep a ra tions 21%
throat prep a ra tions 16%
antivaricosis/antihemorrhoidal prep a ra tions
14%
CNS drugs other 5%
© 2009 IMS Health In cor po rated or its af fil i ates Page 153